Investing in Healthcare Innovation
At MPM, we focus equally on capturing and creating value. We capture value by identifying under-appreciated assets and by understanding risk. We "create" value by doing whatever it takes to help our companies succeed.
Latest News
Jul 21, 2010 BV 4 Portfolio Company Alnara Pharmaceuticals: Lilly Announces Completion of Acquisition
Jul 08, 2010 BV 4 Portfolio Company iPierian Closes $22 Million Series B Financing Led By Google Ventures
Jul 06, 2010 BV 2 Portfolio Company SenoRx Completes Sale to C. R. Bard
Jul 02, 2010 BV 4 Portfolio Company Alnara Pharmaceuticals to be Acquired by Lilly
Jun 28, 2010 BV 4 Portfolio Company Chiasma Receives Orphan Drug Designation From The FDA
